Reduced ACE2 and TMPRSS2 immunopositive bronchial cells in asthmatics after inhaled allergen challenge.
C. Whetstone (Hamilton, Canada), M. Ranjbar (Hamilton, Canada), N. Alsaji (Hamilton, Canada), D. Al-Sajee (Hamilton, Canada), L. Wiltshire (Hamilton, Canada), J. Wattie (Hamilton, Canada), P. O'Byrne (Hamilton, Canada), R. Cusack (Hamilton, Canada), R. Sehmi (Hamilton, Canada), G. Gauvreau (Hamilton, Canada)
Source: International Congress 2022 – Pearls in airway immunology: from mouse to man
Session: Pearls in airway immunology: from mouse to man
Session type: Oral Presentation
Number: 2203
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Whetstone (Hamilton, Canada), M. Ranjbar (Hamilton, Canada), N. Alsaji (Hamilton, Canada), D. Al-Sajee (Hamilton, Canada), L. Wiltshire (Hamilton, Canada), J. Wattie (Hamilton, Canada), P. O'Byrne (Hamilton, Canada), R. Cusack (Hamilton, Canada), R. Sehmi (Hamilton, Canada), G. Gauvreau (Hamilton, Canada). Reduced ACE2 and TMPRSS2 immunopositive bronchial cells in asthmatics after inhaled allergen challenge.. 2203
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|